Skip to main content
FinSpry Logo
FinSpry
IONS logo
IONS
(NASDAQ)
Ionis Pharmaceuticals, Inc.
$55.87-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Ionis Pharmaceuticals, Inc. (IONS) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Ionis Pharmaceuticals, Inc. stock.

Analyst Consensus Rating

Investment consensus from 20 professional research analysts

Consensus Rating

Buy
Based on 20 unique analysts
(39 total ratings in last 90 days)
Very High Confidence∞:1 Buy/Sell

Average Price Target

$100.11
↑ 79.18% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest IONS Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Mitchell Kapoor
HC Wainwright
BuyReiterates
$130.00 → $125.00
Luca Issi
RBC Capital
BuyMaintains
$100.00 → $85.00
Gary Nachman
Canaccord Genuity
BuyMaintains
$110.00 → $95.00
Salveen Richter
Goldman Sachs
HoldMaintains
$75.00 → $68.00
Eliana Merle
Barclays
BuyMaintains
$115.00 → $90.00
Eric Joseph
Citi
BuyMaintains
$115.00 → $100.00
Unknown Analyst
Wells Fargo
BuyReiterates
$100.00
Michael Ulz
Morgan Stanley
BuyMaintains
$130.00 → $110.00
Eliana Merle
Barclays
BuyMaintains
$115.00
Gary Nachman
Canaccord Genuity
BuyMaintains
$110.00
Mitchell Kapoor
HC Wainwright
BuyReiterates
$125.00 → $130.00
Jason Gerberry
BofA Securities
BuyMaintains
$111.00
Jessica Fye
JP Morgan
BuyReiterates
$80.00 → $90.00
Yanan Zhu
Wells Fargo
BuyMaintains
$100.00
Joseph Stringer
Needham
BuyMaintains
$105.00
Michael Ulz
Morgan Stanley
BuyReiterates
$130.00
Gary Nachman
Canaccord Genuity
BuyMaintains
$110.00
Myles Minter
William Blair
BuyMaintains
-
Yaron Werber
TD Cowen
BuyReiterates
$108.00
Salveen Richter
Goldman Sachs
HoldMaintains
$74.00 → $75.00
Jason Gerberry
BofA Securities
BuyMaintains
$111.00
Jessica Fye
JP Morgan
BuyReiterates
$80.00 → $90.00
Michael Ulz
Morgan Stanley
BuyReiterates
$130.00
Akash Tewari
Jefferies
BuyMaintains
$113.00
Yaron Werber
TD Cowen
BuyReiterates
$108.00
Michael Ulz
Morgan Stanley
BuyReiterates
$130.00
Jason Gerberry
BofA Securities
BuyReiterates
$111.00
Gary Nachman
Canaccord Genuity
BuyMaintains
$110.00
Unknown Analyst
Guggenheim
BuyMaintains
$106.00
Mitchell Kapoor
HC Wainwright
BuyReiterates
$125.00
Edmund Ingham
Forbes
BuyInitiates Coverage
-
Myles Minter
William Blair
BuyReiterates
-
Eric Joseph
Citi
BuyInitiates
$90.00
Eliana Merle
Barclays
BuyMaintains
$115.00
Joseph Stringer
Needham
BuyMaintains
$105.00
Paul Matteis
Stifel Nicolaus
HoldMaintains
$83.00 → $86.00
Justin Kim
Oppenheimer
BuyInitiates Coverage
$104.00 → $110.00
Luca Issi
RBC Capital
BuyMaintains
$95.00 → $100.00
Allison Bratzel
Piper Sandler
BuyMaintains
$100.00

Frequently Asked Questions

What is the analyst consensus rating for IONS?

The analyst consensus rating for IONS is "Buy" based on 20 analyst recommendations.

What is the average price target for IONS?

The average 12-month price target for IONS is $100.11, representing an upside of 79.2% from the current price of $55.87.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.